Abstract
Blockade of the human ether-a-go-go related gene 1 (hERG1) channel has been associated with an increased duration of ventricular repolarization, causing prolongation of the time interval between Q and T waves (long QT syndrome, or LQTS). LQTS may result in serious cardiovascular disorders such as tachyarrhythmia and sudden cardiac death. Diverse types of organic compounds bind to the wide intracellular cavity in the pore domain of hERG channels, leading to a full or partial blockade of ion current through the pore. The drug– induced blockade of the hERG-related component of the potassium current is thought to be a major reason for drug– induced arrhythmias in humans. Identification of specific interactions governing the high-affinity blockade of cardiac potassium (K–) channels is crucial both for the prevention of unintended ion channel block and for the design of ion channel modulators. A plethora of ligand- and receptor-based models of K-channels have been created to address these challenges. In this paper, we review the current state of knowledge regarding the structure-function relationship of hERG and discuss progress in the use of molecular modeling for developing both blockers and activators of hERG.
Keywords: hERG, biological channels, long QT syndrome, channel activation and blockade, blockers and activators of hERG, hERG screening, potent modeling strategies of ion channels, hERG1, Drugs, ventricular repolarization, ligand- and receptor-based models, structure-function relationship, potent modeling, strategies of ion channels, transmembrane, anti-arrhythmic activity, proarrhythmic-drug-induced LQTS, non-cardiac medications, antibiotics, antihistamines, antibacterials, terfenadine, cisapride, astemizole, grepafloxin
Current Medicinal Chemistry
Title: Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs
Volume: 17 Issue: 30
Author(s): S. Durdagi, J. Subbotina, J. Lees-Miller, J. Guo, H. J. Duff and S. Y. Noskov
Affiliation:
Keywords: hERG, biological channels, long QT syndrome, channel activation and blockade, blockers and activators of hERG, hERG screening, potent modeling strategies of ion channels, hERG1, Drugs, ventricular repolarization, ligand- and receptor-based models, structure-function relationship, potent modeling, strategies of ion channels, transmembrane, anti-arrhythmic activity, proarrhythmic-drug-induced LQTS, non-cardiac medications, antibiotics, antihistamines, antibacterials, terfenadine, cisapride, astemizole, grepafloxin
Abstract: Blockade of the human ether-a-go-go related gene 1 (hERG1) channel has been associated with an increased duration of ventricular repolarization, causing prolongation of the time interval between Q and T waves (long QT syndrome, or LQTS). LQTS may result in serious cardiovascular disorders such as tachyarrhythmia and sudden cardiac death. Diverse types of organic compounds bind to the wide intracellular cavity in the pore domain of hERG channels, leading to a full or partial blockade of ion current through the pore. The drug– induced blockade of the hERG-related component of the potassium current is thought to be a major reason for drug– induced arrhythmias in humans. Identification of specific interactions governing the high-affinity blockade of cardiac potassium (K–) channels is crucial both for the prevention of unintended ion channel block and for the design of ion channel modulators. A plethora of ligand- and receptor-based models of K-channels have been created to address these challenges. In this paper, we review the current state of knowledge regarding the structure-function relationship of hERG and discuss progress in the use of molecular modeling for developing both blockers and activators of hERG.
Export Options
About this article
Cite this article as:
Durdagi S., Subbotina J., Lees-Miller J., Guo J., J. Duff H. and Y. Noskov S., Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs, Current Medicinal Chemistry 2010; 17 (30) . https://dx.doi.org/10.2174/092986710792927886
DOI https://dx.doi.org/10.2174/092986710792927886 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Updates of N-Type Calcium Channel Blockers with Therapeutic Potential for Neuropathic Pain and Stroke
Current Topics in Medicinal Chemistry Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design Cardiac Tissue Engineering
Recent Patents on Regenerative Medicine Sympathetic Activation in Congestive Heart Failure: Evidence, Consequences and Therapeutic Implications
Current Vascular Pharmacology Bedtime Hypertension Chronotherapy: Concepts and Patient Outcomes
Current Pharmaceutical Design Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences
New Emirates Medical Journal Genetics of Atrial Fibrilation: In Search of Novel Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets Aging as an Evolvability-Increasing Program Which can be Switched Off by Organism to Mobilize Additional Resources for Survival
Current Aging Science Remote Preconditioning- Endocrine Factors in Organ Protection Against Ischemic Injury
Endocrine, Metabolic & Immune Disorders - Drug Targets New Electrocardiographic Features in Brugada Syndrome
Current Cardiology Reviews Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design Cardiac Chamber Volumetric Assessment Using 3D Ultrasound - A Review
Current Pharmaceutical Design Speculative Considerations about Some Cardiology Enigmas
Current Cardiology Reviews Exercise Induced Cardioprotection: An Overview of a Unique Form of Preconditioning
Current Cardiology Reviews Stroke as a Consequence of Sleep Apnea: Epidemiology, Pathophysiology and Treatment Strategies
Current Respiratory Medicine Reviews Bedaquiline: A New Hope for Shorter and Better Anti-Tuberculosis Regimens
Recent Patents on Anti-Infective Drug Discovery COVID-19: An Update on Pathogenesis and Treatment
Current Pharmaceutical Design Physiological Pacing - Quo Vadis?
Current Cardiology Reviews The Role of Vascular Endothelial Growth Factor Gene as the Genetic Marker of Atherothrombotic Disorders and in the Gene Therapy of Coronary Artery Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry